Sebastian Haertter

Binger Str. 173
Ingelheim Am Rhein, RP 55216, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large Populations.

Pre-Emptive Drug Safety Evaluation of Iclepertin (BI-425809) Using Real-World Data and Virtual Addition of This Medication to the Actual Drug Regimen of Individuals from Large Populations.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 30, 2025

Representation of Older Adult Patients in Clinical Trials.

Representation of Older Adult Patients in Clinical Trials.

Journal: Clinical and translational science

Published: August 20, 2025

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges.

Physiologically-Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges.

Journal: CPT: pharmacometrics & systems pharmacology

Published: May 30, 2025

How Clinical Pharmacology Can Support Clinical Trial Diversity and Inclusion.

How Clinical Pharmacology Can Support Clinical Trial Diversity and Inclusion.

Journal: Clinical and translational science

Published: March 21, 2025

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference.

The Global Bioequivalence Harmonisation Initiative (GBHI): Report of the sixth international EUFEPS/PQRI conference.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 28, 2025

Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10-17 years with type 2 diabetes mellitus.

Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10-17 years with type 2 diabetes mellitus.

Journal: British journal of clinical pharmacology

Published: July 05, 2024

New Insights Into Hepatic Impairment (HI) Trials.

New Insights Into Hepatic Impairment (HI) Trials.

Journal: Clinical and translational science

Published: June 19, 2024

Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.

Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper.

Journal: Clinical pharmacology and therapeutics

Published: March 21, 2024

Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failure.

Clinical pharmacokinetics and pharmacodynamics of empagliflozin in patients with heart failure.

Journal: British journal of clinical pharmacology

Published: January 23, 2024

To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias.

To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias.

Journal: Clinical and translational science

Published: June 29, 2021

Effect of itraconazole on the pharmacokinetics of faldaprevir in healthy subjects.

Effect of itraconazole on the pharmacokinetics of faldaprevir in healthy subjects.

Journal: Die Pharmazie

Published: May 09, 2021

Roadmap to 2030 for Drug Evaluation in Older Adults.

Roadmap to 2030 for Drug Evaluation in Older Adults.

Journal: Clinical pharmacology and therapeutics

Published: March 23, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026